|
|
||||||||||||||
|
|
|||||||||||||||
a Department of
Respiratory Medicine, Glenfield Hospital, Leicester LE3 9QP, UK, b Department of Sports Science,
Loughborough University of Technology, UK
Correspondence to: Dr S M Revill.
Received 9 February 1998; Returned to authors 8 May 1998; Revised version received 17 September 1998; Accepted for publication 12 November 1998
BACKGROUND
The purpose
of this study was to develop an externally controlled, constant paced
field walking test to assess endurance capacity in patients with
chronic obstructive pulmonary disease (COPD). There were four
objectives: (1) to develop a protocol; (2) to compare treadmill and
shuttle walk tests of endurance capacity; (3) to examine the
repeatability of the endurance shuttle walk test; and (4) to compare
the sensitivity to pulmonary rehabilitation of endurance and
incremental shuttle walk tests.
METHODS
The test was
designed to complement the incremental shuttle walk test (ISWT) using
the same 10 m shuttle course and an audio signal to control pace. The
intensity of the field endurance test was related to a percentage of
each patient's maximum field exercise performance assessed by the
ISWT. A number of cassette tapes were pre-recorded with a range of
audio signal frequencies to dictate walking speeds between 1.80 and
6.00 km/h. In the first limb of the study 10 patients with COPD (mean
(SD) forced expiratory volume in one second (FEV1) 1.0 (0.36) l, 35% predicted) performed three endurance shuttle walk tests
(ESWTs) and three treadmill endurance tests. The walking speeds were
calculated to elicit 75%, 85%, and 95% of each patient's maximum
ISWT performance for the field tests and measured peak oxygen
consumption for the treadmill tests. In a separate group of patients
the repeatability of the ESWT at an intensity of 85% of the ISWT
performance was evaluated. Finally, the ESWT (at the 85% intensity)
and the ISWT were performed at the start of a five week control period
and at the start and end of a seven week pulmonary rehabilitation
programme in 21 patients with COPD (mean FEV1 0.80 (0.18) l).
RESULTS
The mean (SE)
times achieved during the ESWT were 13.1 (2.3), 10.2 (2.5), and 5.3 (1.7) min for the walks at 75%, 85%, and 95% intensities,
respectively. Patients tended to walk for longer on the treadmill than
during the field tests at all intensities, but there were no
significant differences between the end of test heart rates or Borg
ratings of breathlessness or perceived exertion. Following one practice
ESWT at the 85% intensity, the mean difference and limits of agreement
(2SD) between tests 2 and 3 was +15 (42) s (p>0.05). There was no
significant change in performance on either test following the five
week control period prior to rehabilitation. Following rehabilitation
the ESWT duration increased by 160 (24)% and the ISWT distance
increased by 32 (11)% (effect sizes 2.90 and 0.41, respectively).
CONCLUSIONS
The ESWT
was simple to perform, acceptable to all patients, and exhibited good
repeatability after one practice walk. The test showed major
improvement following rehabilitation and was more sensitive to change
than the field test of maximal capacity.
This article has been cited by other articles:
![]() |
C. J. Sandland, M. D. L. Morgan, and S. J. Singh Patterns of Domestic Activity and Ambulatory Oxygen Usage in COPD Chest, October 1, 2008; 134(4): 753 - 760. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Faager, A. Stahle, and F. Larsen Influence of spontaneous pursed lips breathing on walking endurance and oxygen saturation in patients with moderate to severe chronic obstructive pulmonary disease Clinical Rehabilitation, August 1, 2008; 22(8): 675 - 683. [Abstract] [PDF] |
||||
![]() |
S. J. Deacon, E. E. Vincent, P. L. Greenhaff, J. Fox, M. C. Steiner, S. J. Singh, and M. D. Morgan Randomized Controlled Trial of Dietary Creatine as an Adjunct Therapy to Physical Training in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., August 1, 2008; 178(3): 233 - 239. [Abstract] [Full Text] [PDF] |
||||
![]() |
P P Walker, A Burnett, P W Flavahan, and P M A Calverley Lower limb activity and its determinants in COPD Thorax, August 1, 2008; 63(8): 683 - 689. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Brouillard, V. Pepin, J. Milot, Y. Lacasse, and F. Maltais Endurance shuttle walking test: responsiveness to salmeterol in COPD Eur. Respir. J., March 1, 2008; 31(3): 579 - 584. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jenkins Which is the best exercise test to assess therapeutic intervention in COPD? Chronic Respiratory Disease, February 1, 2008; 5(1): 3 - 5. [PDF] |
||||
![]() |
M. Cazzola, W. MacNee, F. J. Martinez, K. F. Rabe, L. G. Franciosi, P. J. Barnes, V. Brusasco, P. S. Burge, P. M. A. Calverley, B. R. Celli, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers Eur. Respir. J., February 1, 2008; 31(2): 416 - 469. [Abstract] [Full Text] [PDF] |
||||
![]() |
M D L Morgan and S J Singh Assessing the exercise response to a bronchodilator in COPD: time to get off your bike? Thorax, April 1, 2007; 62(4): 281 - 283. [Full Text] [PDF] |
||||
![]() |
V. Pepin, J. Brodeur, Y. Lacasse, J. Milot, P. LeBlanc, F. Whittom, and F. Maltais Six-minute walking versus shuttle walking: responsiveness to bronchodilation in chronic obstructive pulmonary disease Thorax, April 1, 2007; 62(4): 291 - 298. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Palange, S. A. Ward, K-H. Carlsen, R. Casaburi, C. G. Gallagher, R. Gosselink, D. E. O'Donnell, L. Puente-Maestu, A. M. Schols, S. Singh, et al. Recommendations on the use of exercise testing in clinical practice Eur. Respir. J., January 1, 2007; 29(1): 185 - 209. [Abstract] [Full Text] [PDF] |
||||
![]() |
SarahJ. Deacon, EmmaE. Vincent, SallyJ. Singh, MichaelC. Steiner, P. Greenhaff, and MichaelD. Morgan Does creatine supplementation enhance the effects of physical training during pulmonary rehabilitation in COPD? Eur. Respir. Rev., December 1, 2006; 15(101): 187 - 189. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rich The current treatment of pulmonary arterial hypertension: time to redefine success. Chest, October 1, 2006; 130(4): 1198 - 1202. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Sewell, S J Singh, J E A Williams, R Collier, and M D L Morgan How long should outpatient pulmonary rehabilitation be? A randomised controlled trial of 4 weeks versus 7 weeks Thorax, September 1, 2006; 61(9): 767 - 771. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Laude, N. C. Duffy, C. Baveystock, B. Dougill, M. J. Campbell, R. Lawson, P. W. Jones, and P. M. Calverley The Effect of Helium and Oxygen on Exercise Performance in Chronic Obstructive Pulmonary Disease: A Randomized Crossover Trial Am. J. Respir. Crit. Care Med., April 15, 2006; 173(8): 865 - 870. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Brooks and S Solway Should the endurance shuttle walk test replace the six-minute walk test in individuals with chronic obstructive pulmonary disease? Chronic Respiratory Disease, January 1, 2006; 3(1): 1 - 2. [PDF] |
||||
![]() |
T Eaton, P Young, K Nicol, and J Kolbe The endurance shuttle walking test: a responsive measure in pulmonary rehabilitation for COPD patients Chronic Respiratory Disease, January 1, 2006; 3(1): 3 - 9. [Abstract] [PDF] |
||||
![]() |
V. Pepin, D. Saey, F. Whittom, P. LeBlanc, and F. Maltais Walking versus Cycling: Sensitivity to Bronchodilation in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., December 15, 2005; 172(12): 1517 - 1522. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Sewell, S. J. Singh, J. E.A. Williams, R. Collier, and M. D.L. Morgan Can Individualized Rehabilitation Improve Functional Independence in Elderly Patients With COPD? Chest, September 1, 2005; 128(3): 1194 - 1200. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Casas, J. Vilaro, R. Rabinovich, A. Mayer, J. A. Barbera, R. Rodriguez-Roisin, and J. Roca Encouraged 6-min Walking Test Indicates Maximum Sustainable Exercise in COPD Patients Chest, July 1, 2005; 128(1): 55 - 61. [Abstract] [Full Text] [PDF] |
||||
![]() |
J P Fuld, L P Kilduff, J A Neder, Y Pitsiladis, M E J Lean, S A Ward, and M M Cotton Creatine supplementation during pulmonary rehabilitation in chronic obstructive pulmonary disease Thorax, July 1, 2005; 60(7): 531 - 537. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Johnson Which Exercise Test Should Be Used for Patients With Symptomatic COPD? Chest, September 1, 2004; 126(3): 668 - 670. [Full Text] [PDF] |
||||
![]() |
J P Fuldl and M M Cotton Performance enhancement in chronic obstructive pulmonary disease Chronic Respiratory Disease, April 1, 2004; 1(2): 95 - 98. [Abstract] [PDF] |
||||
![]() |
M C Steiner, R L Barton, S J Singh, and M D L Morgan Nutritional enhancement of exercise performance in chronic obstructive pulmonary disease: a randomised controlled trial Thorax, September 1, 2003; 58(9): 745 - 751. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. D.-C. Man, M. G. G. Soliman, J. Gearing, S. G. Radford, G. F. Rafferty, B. J. Gray, M. I. Polkey, and J. Moxham Symptoms and Quadriceps Fatigability after Walking and Cycling in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., September 1, 2003; 168(5): 562 - 567. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.O. Crapo, R.L. Jensen, and F.E. Hargreave Airway inflammation in COPD: physiological outcome measures and induced sputum Eur. Respir. J., June 1, 2003; 21(41_suppl): 19S - 28s. [Abstract] [Full Text] [PDF] |
||||
![]() |
M D L Morgan and J R Britton Chronic obstructive pulmonary disease * 8: Non-pharmacological management of COPD Thorax, May 1, 2003; 58(5): 453 - 457. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Eaton, J.E. Garrett, P. Young, W. Fergusson, J. Kolbe, S. Rudkin, and K. Whyte Ambulatory oxygen improves quality of life of COPD patients: a randomised controlled study Eur. Respir. J., August 1, 2002; 20(2): 306 - 312. [Abstract] [Full Text] [PDF] |
||||
![]() |
ATS Statement: Guidelines for the Six-Minute Walk Test Am. J. Respir. Crit. Care Med., July 1, 2002; 166(1): 111 - 117. [Full Text] [PDF] |
||||
![]() |
R. Aalbers, J. Ayres, V. Backer, M. Decramer, P.A. Lier, P. Magyar, J. Malolepszy, R. Ruffin, and G.W. Sybrecht Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial Eur. Respir. J., May 1, 2002; 19(5): 936 - 943. [Abstract] [Full Text] [PDF] |
||||
![]() |
Managing passengers with respiratory disease planning air travel: British Thoracic Society recommendations Thorax, April 1, 2002; 57(4): 289 - 304. [Full Text] [PDF] |
||||
![]() |
British Thoracic Society Standards of Care Subcomm Pulmonary rehabilitation Thorax, November 1, 2001; 56(11): 827 - 834. [Full Text] [PDF] |
||||
![]() |
B. Schonhofer, S. Wallstein, C. Wiese, and D. Kohler Noninvasive Mechanical Ventilation Improves Endurance Performance in Patients With Chronic Respiratory Failure Due to Thoracic Restriction Chest, May 1, 2001; 119(5): 1371 - 1378. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Solway, D. Brooks, Y. Lacasse, and S. Thomas A Qualitative Systematic Overview of the Measurement Properties of Functional Walk Tests Used in the Cardiorespiratory Domain Chest, January 1, 2001; 119(1): 256 - 270. [Abstract] [Full Text] [PDF] |
||||
![]() |
P M A CALVERLEY Supplementary oxygen therapy in COPD: is it really useful? Thorax, July 1, 2000; 55(7): 537 - 538. [Full Text] |
||||
![]() |
N AMBROSINO Field tests in pulmonary disease Thorax, March 1, 1999; 54(3): 191 - 193. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |